Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project
暂无分享,去创建一个
L. Hemkens | M. Briel | H. Ewald | M. Joerger | B. Kasenda | U. Novak | S. Diem | K. M. Mc Cord | A. Schmitt | A. Hoogkamer | S. Sricharoenchai | A. Herbrand